Breast – Invasive breast cancer of no special type (NST) with faint TLE1 staining of few tumor cells
Breast – Invasive breast cancer of no special type (NST) with weak to moderate TLE1 staining of a fraction of tumor cells
Breast – Invasive breast cancer of no special type (NST) with weak to moderate TLE1 staining of tumor cells
Breast – Invasive lobular breast cancer with strong TLE1 staining of all tumor cells
Colon – Colorectal adenocarcinoma with moderate TLE1 staining of tumor cells
Colon – Colorectal adenocarcinoma with weak to moderate TLE1 positivity of tumor cells
Esophagus – Adenocarcinoma with faint TLE1 immunostaining of few tumor cells
Esophagus – Squamous cell carcinoma with variable, weak to strong TLE1 staining of tumor cells
Kidney – Oncocytoma with faint TLE1 immunostaining of most tumor cells
Kidney – Papillary renal cell carcinoma with weak TLE1 staining of most tumor cells
Kidney – TLE1 negative clear cell carcinoma. TLE1 staining is prominent in tumor-associated endothelial cells
Oral cavity – Squamous cell carcinoma with strong TLE1 immunostaining of tumor cells
Ovary – Clear cell carcinoma with strong TLE1 immunostaining of tumor cells
Ovary – Endometroid carcinoma with strong TLE1 immunostaining of tumor cells
Ovary – Serous high-grade carcinoma with faint TLE1 staining of a small subset of tumor cells
Pharynx – Squamous cell carcinoma with moderate to strong TLE1 staining of most tumor cells
Pharynx – Squamous cell carcinoma with weak TLE1 positivity of a fraction of tumor cells
Prostate – Adenocarcinoma (Gleason 3+3=6) with weak TLE1 immunostaining of tumor cells. Tumor cell staining is weaker than in adjacent normal acinar cells
Prostate – Adenocarcinoma (Gleason 4+4=8) with moderate to strong TLE1 immunostaining of tumor cells
Soft tissue – Synovial sarcoma with strong TLE1 immunostaining of tumor cells
Soft tissue – Synovial sarcoma with strong TLE1 positivity of all tumor cells
Soft tissue – Synovial sarcoma with strong TLE1 staining of tumor cells
GeneTex
